AN2 Therapeutics ANTX
NASDAQ ANTX
$4.46 +0.13 (+3.00%)
At close: Nov 11, 2026 · 4:00 PM EST

AN2 Therapeutics (ANTX) Total Non-Current Liabilities (2024 - 2026)

Updated

AN2 Therapeutics (ANTX) recorded Total Non-Current Liabilities of $5.59 million in Q2 2026, up 0.4% from the prior quarter.

Analysis

AN2 Therapeutics (ANTX) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, AN2 Therapeutics reported Total Non-Current Liabilities of $8.72 million, down 14.8% from FY2024.

  • Across earlier years, Total Non-Current Liabilities came in at $10.24 million in FY2024.
  • Quarterly Total Non-Current Liabilities has ranged from $5.56 million in Q1 2026 to $10.24 million in Q4 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 AN2 Therapeutics 164.30 Mn -121.79 Mn - 6.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.28 Mn
Jun 30, 2026 5.59 Mn
Mar 31, 2026 5.56 Mn
Dec 31, 2025 8.72 Mn
Dec 31, 2024 10.24 Mn
API Access

AN2 Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ANTX&period=max&api_key=YOUR_API_KEY